Fig 1.
PRISMA flow diagram.
Table 1.
Summary of study characteristics1.
Table 2.
Study outcomes—Introducing and enhancing ACT use (without diagnostics), and broader private sector strategies including ACT—% (95% CI or SD) [SE].
Table 3.
Study outcomes—Introducing and enhancing RDT and ACT use, and introducing and enhancing iCCM—% (95% CI where available).